Interestingly, two studies of both ex vivo-expanded iNKT cells and CAR-iNKT cells have demonstrated that the most persistent effector populations – that retain anti-tumor function and maintain longevity within the TME – are those that express CD62L (62) and are transduced with IL-15 (63). Here, IL15 is linked to neoplasm.